Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00335972 · ClinicalTrials.gov registry record · Phase 4
The Effects of Dexmedetomidine and Remifentanil on Carotid Patients
A Phase 4 study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- Phase 4
- Development phase
- 142
- Enrollment target
NCT00335972 is a Phase 4 study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 142 participants.
The verdict
NCT00335972, a Phase 4 study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 142 participants
- Enrollment target
Study Summary
We propose to test whether intraoperative administration of dexmedetomidine will reduce hemodynamic control in the intra- and post-operative periods and reduces PACU analgesic requirements in patients undergoing carotid endarterectomy.
Interventions
- DRUG Dexmedetomidine
- DRUG Remifentanil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2006-06 |
| Est. Completion | 2008-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00335972
The ClinicalTrials.gov registry entry for NCT00335972 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexmedetomidine is the first listed.
NCT00335972 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00335972 about?
NCT00335972 is a clinical study titled "The Effects of Dexmedetomidine and Remifentanil on Carotid Patients". We propose to test whether intraoperative administration of dexmedetomidine will reduce hemodynamic control in the intra- and post-operative periods and reduces PACU analgesic requirements in patients undergoing carotid endarterectomy.
What is the current status of trial NCT00335972?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 142 participants. The study started on 2006-06. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00335972?
The interventions under investigation include: Dexmedetomidine (DRUG), Remifentanil (DRUG).
Who is sponsoring clinical trial NCT00335972?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.